ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

VCNX Vaccinex Inc

4.86
0.06 (1.25%)
20 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Vaccinex Inc VCNX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.06 1.25% 4.86 09:00:00
개장가 저가 고가 종가 전일 종가
4.63 4.63 5.0099 4.86 4.80
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/04/202421:30GLOBEVaccinex Reports 2023 Financial Results and Provides..
27/03/202421:30GLOBEVaccinex, Inc. Announces $1.5 Million Registered Direct..
05/03/202406:19EDGAR2Form 8-K - Current report
22/02/202400:10EDGAR2Form 8-K - Current report
21/02/202422:00GLOBEVaccinex Announces Multiple New Agreements for Access to..
15/02/202422:06EDGAR2Form 8-K - Current report
15/02/202422:00GLOBEVaccinex, Inc. Announces Reverse Stock Split
14/02/202406:30EDGAR2Form 8-K - Current report
14/02/202406:15EDGAR2Form SC 13D/A - General statement of acquisition of..
13/02/202406:22EDGAR2Form SC 13D/A - General statement of acquisition of..
10/02/202406:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/02/202422:20EDGAR2Form 8-K/A - Current report: [Amend]
08/02/202405:43EDGAR2Form 8-K - Current report
07/02/202422:00GLOBEVaccinex Announces Pricing of $3.7 Million PIPE Financing
22/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
20/01/202406:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/01/202407:16EDGAR2Form S-3 - Registration statement under Securities Act of..
09/01/202406:16EDGAR2Form DEF 14A - Other definitive proxy statements
29/12/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202306:15EDGAR2Form PRE 14A - Other preliminary proxy statements
13/12/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:00GLOBENasdaq Grants Vaccinex Extension Until March 4, 2024 to..
13/11/202322:00GLOBEVaccinex Reports Third Quarter 2023 Financial Results and..
13/11/202321:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202305:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202322:00GLOBEVaccinex Reports Clinical Benefit in Interim Analyses from..
26/10/202322:30EDGAR2Form 8-K - Current report
26/10/202322:30GLOBEVaccinex Reports Positive Effect of Pepinemab Treatment on..
26/10/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202305:15EDGAR2Form SC 13D/A - General statement of acquisition of..
14/10/202305:54EDGAR2Form 8-K - Current report
13/10/202305:30EDGAR2Form SC 13D/A - General statement of acquisition of..
06/10/202305:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:20EDGAR2Form 8-K - Current report
02/10/202322:16EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
29/09/202309:41EDGAR2Form S-1MEF - Registration adding securities to prior Form..
27/09/202321:00EDGAR2Form 8-K - Current report
27/09/202305:15EDGAR2Form SC 13D/A - General statement of acquisition of..
26/09/202321:06EDGAR2Form 8-K - Current report
26/09/202321:01EDGAR2Form S-1/A - General form for registration of securities..
26/09/202305:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/09/202305:37EDGAR2Form 8-K - Current report
23/09/202305:21EDGAR2Form 8-K - Current report
15/09/202306:26EDGAR2Form S-1 - General form for registration of securities under..
13/09/202319:46EDGAR2Form 8-K - Current report
23/08/202305:31EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock